(Total Views: 564)
Posted On: 03/04/2025 12:05:40 PM
Post# of 155790
Would people like to chime in on how long a TNBC preclinical study trying to better clarify the MOA in oncology might take? Or a TNBC preclinical seeking to determine if there are potential synergies with leronlimab and antibody-drug conjugates and immune checkpoint inhibitors?
Although the September 9, 2024 press release mentioned these things, I interpret the December 17, 2024 press release to mean that they were perhaps about to start that work in December.
From a few things I've seen, xenograft studies can be as little as a couple of months study time plus more for analysis. I did notice that SMC Labs does offer xenograft services, and wonder if the "great collaboration with CytoDyn Inc." (2/28/2025 Fibrosis news posted at SMC website) extends to TNBC work.
I've also glanced at some papers developing other TNBC murine models that have much longer timelines, but I wonder what the collective wisdom on this board has to say in speculating about TNBC preclinical study length.
Although the September 9, 2024 press release mentioned these things, I interpret the December 17, 2024 press release to mean that they were perhaps about to start that work in December.
From a few things I've seen, xenograft studies can be as little as a couple of months study time plus more for analysis. I did notice that SMC Labs does offer xenograft services, and wonder if the "great collaboration with CytoDyn Inc." (2/28/2025 Fibrosis news posted at SMC website) extends to TNBC work.
I've also glanced at some papers developing other TNBC murine models that have much longer timelines, but I wonder what the collective wisdom on this board has to say in speculating about TNBC preclinical study length.
(4)
(0)
There are no guarantees in investing. No one should consider these pages or posts to be financial advice. Everyone has a responsibility to verify and thoroughly learn more than what is referenced or written here, and everyone must take responsibility for their own investing decisions.
